Episode 115: The History and Future of Precision Medicine with Ray Kurzrock

Chadi is delighted and honored to host an icon and pioneer in precision medicine and the molecular understanding of cancer as we know it: Ray Kurzrock, MD, FACP, Center Associate Director and Professor at the Medical College of Wisconsin as well as CMO of the WIN consortium. Nobody knows the history of precision medicine like Ray does. She was doubted when she started, but her resilience and perseverance led to unprecedented progress that she led along with her mentors, mentees, and colleagues.She details her early appointment to leading the phase I trials at MD Anderson Cancer Center and developing a protocol for matching targeted therapy trials to the right patients, the origins of the term “precision medicine,” resistance to precision medicine and genomics by different stakeholders, how accelerated approvals are better suited for precision medicine versus randomized controlled trials, and a host of other topics in this riveting and spirited dialogue.We owe much of our current understanding of cancer as a molecularly driven disease to Ray as she had an immeasurable impact on the field.Please visit chadinabhan.com and check out more features. Don't forget to subscribe, like, rate, and share with your friends and colleagues.